bsm-60645R-Cy7 [Conjugated Primary Antibody]
phospho-AKT (Thr308) Recombinant Antibody, Cy7 Conjugated
www.biossusa.com
[email protected]
800.501.7654 [DOMESTIC]
+1.781.569.5821 [INTERNATIONAL]
DATASHEET

Host: Rabbit

Target Protein: phospho-AKT (Thr308)

Modification Site: Thr308

Clonality: Recombinant

Isotype: IgG

Entrez Gene: 208

Swiss Prot: P31751

Source: KLH conjugated synthetic peptide derived from human phospho-AKT (Thr308)

Purification: Purified by Protein A.

Storage Buffer: Aqueous buffered solution containing 0.01M TBS (pH 7.4) with 1% BSA, 0.02% Proclin300 and 50% Glycerol.

Storage: Store at -20°C. Aliquot into multiple vials to avoid repeated freeze-thaw cycles.

Conjugation: Cy7

Excitation/ Emission: 743nm/767nm

Size: 100ul

Concentration: 1ug/ul

Applications: WB(1:300-5000)

Predicted Molecular Weight: 56


Predicted Cross Reactive Species: Mouse

For research use only. Not intended for diagnostic or therapeutic use.

PRODUCT SPECIFIC PUBLICATIONS
  • ingjie Ge. et al. Integrated network toxicology, molecular docking, and in vivo experiments to elucidate molecular mechanism of aflatoxin B1 hepatotoxicity. ECOTOX ENVIRON SAFE. 2024 Apr;275:116278Read more>>
  • Wang Yunyun. et al. Iridoids rich fraction from Valeriana jatamansi Jones promotes axonal regeneration and motor functional recovery after spinal cord injury through activation of the PI3K/Akt signaling pathway. FRONT MOL NEUROSCI. 2024 May;17Read more>>
VALIDATION IMAGES